InMode Ltd. income statement INMD

Annual Quarterly

In fiscal 2025, which ended Dec 31, 2025, InMode Ltd. reported revenue of $370.5 million, down 6.2% from the year before. Net income was $93.8 million, a profit margin of 25.3%. Operating income came to $85.4 million, an operating margin of 23.0%. Diluted earnings per share were $1.43. Across the 7 fiscal years shown, revenue grew from $156.4 million in fiscal 2019 to $370.5 million in fiscal 2025, about 15.5% a year.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
FY 2019
Dec 31, 2019
Revenue
370
-6.2%
395
-19.8%
492
+8.3%
454
+27.0%
358
+73.5%
206
+31.8%
156
Cost of revenue
80
+2.3%
78
-3.7%
81
+9.8%
73
+37.1%
54
+73.7%
31
+52.4%
20
Gross profit
291
-8.2%
317
-22.9%
411
+8.0%
381
+25.3%
304
+73.4%
175
+28.7%
136
Research and development
13
+1.4%
13
-2.0%
13
+7.9%
12
+30.4%
10
+0.7%
9
+66.1%
6
Selling, general and administrative
192
+0.5%
191
-5.4%
202
+18.6%
171
+33.5%
128
+37.5%
93
+31.3%
71
Operating expenses
206
+0.5%
205
-5.2%
216
+17.9%
183
—
102
+33.9%
77
Operating income
85
-24.1%
113
-42.5%
196
-1.1%
198
+18.1%
167
+129.9%
73
+22.2%
60
Interest income
25
-19.4%
31
+43.2%
22
+498.2%
4
+588.0%
1
-84.0%
3
+35.8%
2
Pretax income
110
-23.1%
143
-34.0%
217
+7.8%
201
+19.9%
168
+120.7%
76
+22.7%
62
Income tax
16
+143.6%
-38
-295.4%
19
-51.6%
40
+1264.3%
3
+164.5%
1
+25.4%
1
Net income
94
-48.2%
181
-8.4%
198
+22.5%
162
-2.2%
165
+120.0%
75
+22.7%
61
Basic EPS
1.45
-36.7%
2.29
-3.4%
2.37
+20.9%
1.96
-3.4%
2.03
+95.2%
1.04
+0.0%
1.04
Diluted EPS
1.43
-36.4%
2.25
-2.2%
2.30
+21.7%
1.89
-1.6%
1.92
+115.7%
0.89
+11.2%
0.80
Weighted average shares, basic
65
-18.5%
79
-5.1%
84
+1.3%
82
+1.3%
81
+12.9%
72
+23.4%
58
Weighted average shares, diluted
65
-18.8%
81
-6.2%
86
+0.6%
85
-0.7%
86
+2.2%
84
+10.6%
76
Other measures
Depreciation and amortization
1
-4.5%
1
+16.9%
1
-8.4%
1
+31.5%
1
+24.3%
0
+37.7%
0
EBITDA
86
-24.0%
113
-42.3%
196
-1.1%
199
+18.2%
168
+129.3%
73
+22.3%
60
Margins
Gross margin
78.54%
80.31%
83.60%
83.82%
85.01%
85.03%
87.06%
Operating margin
23.05%
28.50%
39.76%
43.55%
46.84%
35.34%
38.13%
Pretax margin
29.78%
36.34%
44.16%
44.35%
46.99%
36.94%
39.68%
Profit margin
25.33%
45.91%
40.22%
35.56%
46.17%
36.40%
39.11%
EBITDA margin
23.23%
28.69%
39.89%
43.70%
46.98%
35.54%
38.32%
Effective tax rate
14.95%
-26.35%
8.91%
19.83%
1.74%
1.45%
1.42%
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. More on our methodology.

New to this? Read How to Read an Income Statement, With a Real Example.

Company profile

Industry
Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as
INMD (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Israel
Headquarters
Yokneam, Israel
SEC filer status
Large accelerated filer
SEC CIK
1742692

Other Electromedical & Electrotherapeutic Apparatus companies

All 31 Electromedical & Electrotherapeutic Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.